Emami Limited (EMAMILTD) AI Stock Analysis

• Market Cap: ₹236.01B
• Dividend Yield: 1.55%
• Average Volume (3M): 27.33K
• Price to Earnings (P/E): 28.7
• Beta (1Y): 0.64
• Revenue Growth: 4.06%
• EPS Growth: 10.78%
• Country: IN
• Employees: 3,289
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 3.80
• Shares Outstanding: 439,080,050
• 10 Day Avg. Volume: 15,423
• 30 Day Avg. Volume: 27,333
• PEG Ratio: 2.65
• Price to Book (P/B): 9.26
• Price to Sales (P/S): 6.55
• P/FCF Ratio: 29.31
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹720.00
• Price Target Upside: 40.05% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: ₹550.00 ▲(6.98% Upside)

Emami Limited's overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth and profitability margins. However, the technical analysis indicates bearish momentum, which negatively impacts the score. The valuation is reasonable but not particularly attractive. The absence of earnings call data and corporate events means these factors do not influence the score.

Emami Limited Business Overview & Revenue Model

Company Description

Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, vasocare herbal petroleum jelly, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; balm, balm ultra-power, quick relief roll-on, ortho vedic oil, healthcare products, pancharishta, nityam, kesari jivan, and ayurvedic hand sanitizers under the Zandu brand; radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products under the Kesh King brand; pain reliever balm under the Mentho Plus brand; and pain relief ointment under the Fast Relief brand. The company also offers prickly heat powder under the Dermicool brand; non sticky hair oil under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; home hygiene solutions under the Emasol brand; and normal, dry, and ultra-dry skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.

How the Company Makes Money

Emami Limited generates revenue primarily through the sale of its wide range of products across different segments. The company's key revenue streams include sales from personal care products like skin creams, hair oils, and soaps, as well as healthcare products such as ayurvedic medicines and dietary supplements. Additionally, Emami profits from its presence in the food sector, offering products like healthy snacks and cooking oils. Significant partnerships with distribution networks, retail chains, and e-commerce platforms enhance its market reach. The company also invests in brand marketing and innovation to attract consumers, thereby driving sales and contributing to its earnings.

Emami Limited Financial Statement Overview

Summary

Emami Limited demonstrates impressive financial health with robust revenue growth, strong profitability margins, and effective debt management. The company's consistent performance in generating free cash flow and maintaining a high equity ratio underlines its financial stability and operational efficiency. While slight concerns exist regarding fluctuating net income and increasing liabilities, the overall trajectory remains positive, reflecting a well-managed business poised for continued success.

Income Statement

Emami Limited has shown a consistent increase in revenue over the years, with a notable revenue growth rate of 6.45% from 2024 to 2025. The company maintains a strong gross profit margin of 68.64% and a net profit margin of 21.17% in 2025, indicating efficient cost management and profitability. The EBIT and EBITDA margins of 38.70% and 26.52% respectively, further highlight the company's strong operational performance. However, the decline in net income from 2022 to 2023 poses a slight concern for sustained profitability.

Balance Sheet

The balance sheet reflects a solid equity base with an equity ratio of 76.26% in 2025, emphasizing financial stability. The debt-to-equity ratio is low at 0.03, showcasing prudent debt management. Return on equity (ROE) is strong at 29.92%, indicating effective use of shareholder funds to generate profit. A notable strength is the reduction in total debt over the years, though the increase in total liabilities from 2024 to 2025 may warrant monitoring.

Cash Flow

The cash flow statement highlights a robust free cash flow growth rate of 15.28% from 2024 to 2025, driven by increased operating cash flow. The operating cash flow to net income ratio of 1.11 indicates healthy cash generation relative to reported profits. The free cash flow to net income ratio of 1.06 suggests strong cash conversion, although the consistent negative investing and financing cash flows could imply ongoing capital investments and debt repayments.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	38.07B	38.09B	35.78B	34.06B	31.87B	28.81B
Gross Profit	26.29B	26.15B	23.78B	22.04B	20.58B	19.34B
EBITDA	10.67B	10.10B	9.90B	9.14B	10.41B	9.53B
Net Income	8.18B	8.06B	7.24B	6.40B	8.39B	4.55B
Balance Sheet
Total Assets	0.00	35.34B	32.80B	31.10B	30.57B	25.20B
Cash, Cash Equivalents and Short-Term Investments	8.26B	8.26B	4.09B	2.99B	1.83B	4.46B
Total Debt	0.00	897.80M	939.56M	905.10M	2.82B	1.01B
Total Liabilities	-26.93B	8.40B	8.22B	7.97B	9.83B	7.58B
Stockholders Equity	26.93B	26.95B	24.47B	23.03B	20.77B	17.63B
Cash Flow
Free Cash Flow	0.00	8.51B	7.38B	7.08B	1.60B	8.88B
Operating Cash Flow	0.00	8.96B	7.79B	7.49B	6.44B	9.22B
Investing Cash Flow	0.00	-3.40B	-2.05B	-1.13B	-2.35B	-2.27B
Financing Cash Flow	0.00	-5.00B	-5.63B	-6.08B	-4.02B	-6.88B

Emami Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 514.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:EMAMILTD, the sentiment is Negative. The current price of 514.1 is below the 20-day moving average (MA) of 539.32, below the 50-day MA of 563.42, and below the 200-day MA of 576.51, indicating a bearish trend. The MACD of -9.56 indicates Positive momentum. The RSI at 30.61 is Neutral, neither overbought nor oversold. The STOCH value of 16.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:EMAMILTD.

Emami Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ZYDUSWELL	73 Outperform	₹141.50B	55.84	―	0.27%	14.55%	-20.61%
CASTROLIND	72 Outperform	₹191.64B	19.62	―	6.80%	6.83%	8.79%
JYOTHYLAB	68 Neutral	₹115.87B	31.70	―	1.12%	1.59%	-2.52%
FINEORG	66 Neutral	₹133.47B	32.21	―	0.25%	8.41%	-2.59%
EMAMILTD	64 Neutral	₹236.01B	28.68	―	1.55%	4.06%	10.78%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
CROMPTON	57 Neutral	₹182.45B	34.65	―	1.08%	0.73%	-5.88%